Form: 8-K

Current report filing

May 24, 2004

8-K: Current report filing

Published on May 24, 2004

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): May 21, 2004

 

OMEGA HEALTHCARE INVESTORS, INC.

(Exact name of registrant as specified in its charter)

 

Maryland

 

1-11316

 

38-3041398

(State of Incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

9690 Deereco Road, Suite 100
Timonium, Maryland  21093
(410) 427-1700
(Address and telephone number of Registrant)

 

 

 

Item 5.  Other Events.

 

Omega Healthcare Investors, Inc. (the “Company”) is providing updated information relating to the Company’s outstanding common stock and options as of April 30, 2004.  As of April 30, 2004, there were 46,340,599 shares of Omega common stock outstanding and 1,241,408 options to purchase Omega common stock outstanding.  Options for 1,042,217 shares of common stock have been exercised since December 31, 2003.

 

Stock Options Outstanding as of April 30, 2004

(Unaudited)

 

The 1,241,408 options outstanding at April 30, 2004, have a weighted-average remaining contractual life of 6.71 years and an exercise price ranging from $2.32 to $37.20 per share.  A breakdown of the options outstanding at April 30, 2004 by price range is presented below:

 

Option Price
Range

 

Number

 

Weighted Average
Exercise Price

 

Weighted Average
Remaining Life
(Years)

 

Number
Exercisable

 

Weighted Average
Price on Options
Exercisable

 

$2.32

- $3.00

 

581,760

 

$

2.61

 

7.30

 

42,348

 

$

2.37

 

$3.01

- $3.81

 

520,482

 

$

3.20

 

7.85

 

241,376

 

$

3.22

 

$6.02

- $9.33

 

120,165

 

$

6.50

 

7.81

 

105,162

 

$

6.41

 

$20. 25

- $37.20

 

19,001

 

$

28.03

 

3.15

 

19,001

 

$

28.03

 

 

Equity Compensation Plans as of April 30, 2004

 

The following table presents information about our equity compensation plans at April 30, 2004:

 

 

 

Number of Securities to
be Issued
upon Exercise of
Outstanding Options,
Warrants and Rights

 

Weighted Average
Exercise Price of
Outstanding Options,
Warrants and Rights

 

Number of Securities
Remaining Available for
Future Issuance under
Equity Compensation
Plans (excluding
Securities Reflected in
Column (a))

 

Plan Category

 

(a)

 

(b)

 

(c)

 

Equity compensation plans approved by security holders

 

1,241,408

 

$3.62

 

562,070

 

Equity compensation plans not approved by security holders

 

—

 

—

 

—

 

Total

 

1,241,408

 

$3.62

 

562,070

 

 

No equity incentives were granted to executive officers of the Company in 2003 or 2002.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

OMEGA HEALTHCARE INVESTORS, INC.

 

 

 

 

 

By:

/s/ C. Taylor Pickett

 

 

Name: C. Taylor Pickett

 

Title: Chief Executive Officer

 

 

 

 

Dated:  May 24, 2004

 

 

3